First, we documented that NF-κB p65 proteins and NF-κB DNA binding activity were indeed increased in hypoxic pancreatic cancer cells compared with the normoxic counterparts as determined by Western blot analysis and EMSA. The gene discussed is NFKB1; the disease is pancreatic neoplasm.